Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-AMPHETAMINE XR | 5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-05-12 | 2022-07-01 | 160420 |
| TEVA-AMPHETAMINE XR | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-08-18 | 2022-10-29 | 167226 |
| TEVA-AMPHETAMINE XR | 10MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-10-17 | 2023-07-28 | 172027 |
| TEVA-AMPICILLIN | 500MG | CAPSULE | Resolved | 2022-10-28 | 2022-11-12 | 173034 |
| TEVA-AMPICILLIN | 500MG | CAPSULE | Resolved | 2023-10-19 | 2023-11-09 | 207494 |
| TEVA-AMPICILLIN | 250MG | CAPSULE | Resolved | 2020-05-14 | 2020-09-03 | 115210 |
| TEVA-AMPICILLIN | 500MG | CAPSULE | Resolved | 2020-05-14 | 2020-06-25 | 115213 |
| TEVA-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2020-05-01 | 2020-05-14 | 113800 |
| TEVA-ARIPIPRAZOLE | 30MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86825 |
| TEVA-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86945 |
| TEVA-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86948 |
| TEVA-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86951 |
| TEVA-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86954 |
| TEVA-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86957 |
| TEVA-ARIPIPRAZOLE | 30MG | TABLET | Resolved | 2019-06-27 | 2019-10-10 | 87687 |
| TEVA-ATAZANAVIR | 200MG | CAPSULE | Resolved | 2020-04-10 | 2020-04-23 | 111810 |
| TEVA-ATAZANAVIR | 300MG | CAPSULE | Resolved | 2020-04-10 | 2020-07-23 | 111813 |
| TEVA-ATAZANAVIR | 200MG | CAPSULE | Resolved | 2017-08-21 | 2017-09-19 | 19928 |
| TEVA-ATAZANAVIR | 200MG | CAPSULE | Resolved | 2021-01-15 | 2021-01-21 | 131688 |
| TEVA-ATENOLOL | 100MG | TABLET | Resolved | 2020-07-30 | 2020-09-03 | 121515 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
| ACT LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| ACT OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |
| ACT OLMESARTAN | 40MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117500 |
| ACT OLMESARTAN HCT | 40MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117516 |
| ACT OLMESARTAN HCT | 20MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117513 |
| ACT OLMESARTAN HCT | 40MG 25MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117519 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256082 |